Steve Harvey

Steve Harvey is a recognized leader in genomics and synthetic biology, transitioning from academic research to entrepreneurial leadership. As CEO and Co-Founder of Camena Bioscience, he spearheads the development of gSynth™, an innovative enzymatic DNA synthesis platform that significantly improves the accuracy and speed of creating complex gene sequences, addressing critical bottlenecks in pharmaceutical and biotechnology industries. camenabio+3

His extensive academic background includes a PhD in Developmental Biology and research roles at the University of Cambridge and Wellcome Trust Sanger Institute, where he contributed to significant scientific publications, including work on zebrafish development, in journals like Nature and PLOS Biology. theorg+3